Altered degradation of circulating nucleic acids and oligonucleotides in diabetic patients

G Kocic1, G Bjelakovic, Lj Saranac

  • 1Institute of Biochemistry, Medical Faculty University of Nis, Serbia. kocicrg@yahoo.co.uk

Insights

Reduced RNase activity in diabetic patients, particularly juvenile diabetics, leads to increased circulating oligonucleotides. This may promote Toll-like receptor (TLR) activation and immune responses.

Area of Science:

  • Immunology
  • Biochemistry
  • Endocrinology

Background:

  • Circulating nucleotide motifs can activate Toll-like receptors (TLRs), initiating immune responses.
  • Nucleases in blood are crucial for degrading nucleic acids and oligonucleotides.
  • Diabetes mellitus is associated with immune dysregulation.

Purpose of the Study:

  • To investigate plasma RNase and nuclease activity in diabetic patients.
  • To examine the levels of circulating RNA and oligonucleotides in diabetes.
  • To explore the link between reduced nuclease activity, increased nucleic acids, and TLR activation in diabetes.

Main Methods:

  • Assessed plasma RNase and nuclease activity using various substrates (rRNA, poly(C), poly(U), poly(I:C), poly(A:U), CpG).
  • Quantified circulating RNA and oligonucleotides in patients with juvenile insulin-dependent diabetes, adult insulin-dependent diabetes, type 2 diabetes, and age-matched controls.
  • Investigated the effect of glucose on commercial RNase and control plasma enzyme activity to assess non-enzymatic glycation.

Main Results:

  • Plasma RNase and nuclease activity were significantly lower in diabetic patients, especially juvenile diabetics.
  • Total amounts of circulating RNA and oligonucleotides were elevated in diabetic patients compared to controls.
  • Incubation with glucose demonstrated a more significant fall in enzyme activity in control plasma than in commercial RNase, suggesting glycation impacts.

Conclusions:

  • Decreased plasma RNase activity in diabetes contributes to higher levels of circulating oligonucleotides.
  • Elevated nucleic acids may act as 'danger motifs,' potentially activating Toll-like receptors (TLRs).
  • This mechanism could link diabetes to altered immune stimulation and cytokine secretion.

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...